| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $896.5M | $852.3M | $862.6M |
| YoY Revenue Growth % | +5.2% | -1.2% | — |
| Gross Profit | $231.7M | $223.2M | — |
| Gross Margin % | 25.8% | 26.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $14.1M | $10.1M | -$13.3M |
| Operating Margin % | 1.6% | 1.2% | -1.5% |
| Net Income (GAAP) | -$49.2K | -$38.3K | -$75.7K |
| EBITDA (Normalized) | $21.5M | $17.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$11.3M | $22.8M | -$11.0M |
| Capital Expenditures (CapEx) | $9.3M | $9.5M | — |
| Free Cash Flow (FCF) | -$20.6M | $13.3M | -$11.0M |
| FCF Margin % | -2.3% | 1.6% | -1.3% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $18.1M | $35.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$24.5M | $1.7M | — |